Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-056152

President and CEO sold 3,493 shares at $4.54 ($15,858)

From the SEC's structured data for this filing

Trades in this filing

Paulson Richard A. · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-11-04 Sale : show line 1 in the form −3,493 $4.54 $15,858 616,017 D
Open-market sales · 3,493 sh · avg $4.54 · $15,858
Loading xslF345X03/doc4.xml…